Ozempic® (semaglutide) Injection 0.25 mg Pen – 1 Prefilled Pen (NDC: 0169-3212-15)
1 Pack – For Initial Dose Titration

Product Description:

Ozempic® (semaglutide) is a once-weekly GLP-1 receptor agonist indicated for adults with type 2 diabetes to improve glycemic control as an adjunct to diet and exercise. It is also approved to reduce the risk of major cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.

This 0.25 mg Ozempic® pen is typically used during the initial 4-week titration phase before increasing to higher maintenance doses (e.g., 0.5 mg or 1 mg). Each prefilled pen delivers four weekly doses of 0.25 mg, helping patients adjust to treatment and reduce gastrointestinal side effects.

Features:

• Delivers 4 doses of 0.25 mg semaglutide

• Designed for starter/titration phase (not a maintenance dose)

• Once-weekly dosing schedule

• Prefilled, easy-to-use disposable injection pen

• For subcutaneous use in abdomen, thigh, or upper arm

• Needles not included (sold separately)

• One pen per pack